Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide causes nausea because it slows the rate at which your stomach empties food into the small intestine. That gastric-slowing effect is part of how the medicine helps you eat less, but it also means your stomach stays fuller for longer than it's used to — and that produces the queasy feeling most people notice in the early weeks. The NHS medicines page for semaglutide lists nausea as one of the most common side effects of treatment, and clinical trial data echo that picture: in the STEP 1 trial, published in the New England Journal of Medicine, the majority of participants on semaglutide 2.4mg reported gastrointestinal side effects, with nausea being the most frequent. These are prescription-only medicines, so a prescriber will assess whether they are right for you individually before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
GLP-1 receptors are found throughout the gut and in areas of the brain that regulate appetite. Semaglutide activates them, and two things happen. First, the vagus nerve carries a signal of fullness to the brain earlier than usual. Second, the muscle at the bottom of the stomach contracts less freely, so food lingers longer before passing into the intestine. Both effects contribute to eating less. They also mean your digestive system is processing meals in a rhythm it isn't accustomed to, and nausea is the body's way of registering that change.
It is worth knowing that this mechanism is dose-dependent. The starting dose of semaglutide is intentionally low, it is there to let your system acclimatise, not to produce significant weight loss on its own. Nausea tends to be sharpest just after a dose increase, then settles again. If you want a fuller picture of what to expect across the whole treatment journey, our guide to Wegovy side effects covers the pattern from the first pen to maintenance.
The MHRA issued an updated Drug Safety Update in January 2026 reinforcing that gastrointestinal effects are well-recognised with GLP-1 receptor agonists and are generally mild to moderate in severity. Serious cases, including dehydration from prolonged vomiting, are less common but do occur, which is why the guidance emphasises reporting anything that goes beyond ordinary nausea.
In the STEP 1 trial (68 weeks, over 1,900 adults with obesity or overweight, semaglutide 2.4mg versus placebo) nausea was reported by around 44% of the semaglutide group compared with about 16% on placebo. Crucially, most cases were rated mild or moderate, and discontinuation due to gastrointestinal side effects occurred in roughly 4.5% of participants. That means the large majority of people kept going through the uncomfortable early weeks and reached a more settled phase.
The peak tends to come in the first one to four weeks after each dose step. By the time most people reach their maintenance dose, the body has gone through several of these adjustment cycles and the baseline level of nausea has usually dropped considerably. Some people notice it barely at all by that point; others find a low-level queasiness lingers around mealtimes. If you are specifically wondering whether your experience is typical, this page on whether Wegovy makes you feel sick addresses the question in more detail.
Vomiting is less common than nausea but follows the same pattern, most pronounced after a new dose, then fading. Staying hydrated matters more than eating during a bad patch. Sipping water steadily through the day is more effective than drinking a large glass at once.
There is a fair amount of peer-reviewed and clinical trial evidence supporting a handful of dietary adjustments. Smaller, more frequent meals reduce the volume of food sitting in an already-slowed stomach at any one time. Avoiding high-fat meals helps because fat is the slowest macronutrient to clear the stomach regardless of semaglutide, combining the two compounds the delay. The same logic applies to very rich or heavily spiced food in the early weeks.
Timing your injection can make a difference. Some people find that injecting before bed means the worst of the initial reaction happens while they are asleep, so they wake up past the peak. Others prefer mid-morning so they can eat a small breakfast first. Neither is clinically prescribed; it is worth trying both and seeing what suits your routine. One practical note: if you keep your pen in the fridge door, taking it out an hour before injecting and letting it reach room temperature can reduce the sting at the injection site, which some people find makes the whole experience feel more manageable.
If burping is a prominent feature alongside the nausea, this page on excessive burping on Wegovy goes into the specific mechanism and what helps. For broader context, our page on why semaglutide makes you feel sick covers overlapping angles that may answer follow-up questions you have, and if you are trying to work out whether semaglutide can make you feel sick in the first place, that page also sets out what the evidence says before treatment begins. For those already in treatment who find the queasiness harder than expected, our page on why semaglutide can make you feel so sick looks more closely at the reasons some people have a stronger reaction than others.
Most nausea from semaglutide is unpleasant but not dangerous. The signal to act quickly is different: severe, persistent stomach pain that extends toward your back, with or without vomiting, can indicate acute pancreatitis, which the MHRA highlighted in its January 2026 Drug Safety Update on GLP-1 medicines. This is infrequent but serious. Do not try to manage that kind of pain at home.
Other reasons to contact your prescriber promptly include signs of dehydration from repeated vomiting (dizziness when standing, very dark urine, not passing urine for many hours) and any allergic reaction such as swelling of the face or throat. Day-to-day nausea that is manageable does not need an urgent call, but it is always worth mentioning at your next review so your prescriber can consider whether slowing the dose escalation would help.
The MHRA Yellow Card scheme lets you report side effects directly, which contributes to ongoing medicines safety monitoring across the UK. If you are thinking about starting semaglutide treatment and want to understand what to expect before your prescription is written, starting with a free consultation gives you the chance to ask these questions before any decision is made. Our prescribers hear questions about nausea more than almost anything else, it is a reasonable thing to want to understand first.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.